Skip to main content

Advertisement

SpringerLink
Log in

A fatal case of systemic strongyloidiasis and review of the literature

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Systemic strongyloidiasis is a rare but serious complication of intestinal strongyloidiasis. The condition occurs mainly in immunosuppressed patients and has a significant mortality rate. A case of systemic strongyloidiasis is described in a patient who received systemic steroid treatment, and a short review of the literature is given. The increased use of immunosuppressive and cytotoxic treatment necessitates increased awareness of this infection. HIV-infection, however, does not appear to increase the risk of developing systemic strongyloidiasis. Patients from endemic areas and travellers to such areas, even in the remote past, should be examined for strongyloidiasis before being given immunosuppressive treatment. Awareness of the possibility of systemic strongyloidiasis is essential if such a patient develops gastrointestinal or pulmonary symptoms or has repeated episodes of unexplained gram-negative infections while undergoing immunosuppressive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Normand LA Sur la maladie dite diarrhee de Cochin-Chine. Comptes Rendus Hebdomadaires des Seances de L'Academie des Sciences 1876, 83: 316–318.

    Google Scholar 

  2. Genta RM, Walzer PD Strongyloidiasis. In: Walzer PD, Genta RM (ed): Parasitic infections in the compromised host. Marcel Dekker, New York, 1989, p. 463–525.

    Google Scholar 

  3. Cook GC Strongyloides stercoralis hyperinfection syndrome: how often is it missed? Quarterly Journal of Medicine 1987, 244: 625–629.

    Google Scholar 

  4. Longworth DL, Weller PF Hyperinfection syndrome with strongyloidiasis. In: Remington JS, Schwartz MN (ed): Current clinical topics in infectious diseases. McGraw-Hill, New York, 1986, p. 1–26.

    Google Scholar 

  5. Genta RM Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Reviews of Infectious Diseases 1989, 11: 755–767.

    PubMed  Google Scholar 

  6. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB Syndrome of hyperinfection withStrongyloides stercoralis. Reviews of Infectious Diseases 1981, 3: 397–407.

    PubMed  Google Scholar 

  7. Genta RM Strongyloides stercoralis: immunobiological considerations on an unusual worm. Parasitology Today 1986, 2: 241–246.

    PubMed  Google Scholar 

  8. Genta RM Immunobiology of strongyloidiasis. Tropical and Geographical Medicine 1984, 36: 223–229.

    PubMed  Google Scholar 

  9. Neva FA Biology and immunology of human strongyloidiasis. Journal of Infectious Diseases 1986, 153: 397–406.

    PubMed  Google Scholar 

  10. Genta RM Strongyloidiasis in immunodiagnosis of parasitic diseases. In: Walls KW, Schantz PM (ed): Helminthic diseases. Volume 1. Academic Press, Orlando, 1986, p. 183–199.

    Google Scholar 

  11. Scowden EB, Schaffner W, Stone WJ Overwhelming strongyloidiasis. An unappreciated opportunistic infection. Medicine 1978, 57: 527–544.

    PubMed  Google Scholar 

  12. Shiwaku K, Chigusa Y, Kadosaka T, Kaneko K Factors influencing development of free-living generations ofStrongyloides stercoralis. Parasitology 1988, 97: 129–138.

    PubMed  Google Scholar 

  13. Genta RM, Schad GA, Hellman ME Strongyloides stercoralis: parasitological, immunological and pathological observations in immunosuppressed dogs. Transactions of the Royal Society of Tropical Medicine and Hygiene 1986, 80: 34–41.

    PubMed  Google Scholar 

  14. Harper JS, Genta RM, Gam AA, London WI, Neva FA Experimental disseminated strongyloidiasis inErythrocebus patas. I:Pathology. American Journal of Tropical Medicine and Hygiene 1984, 33: 431–443.

    PubMed  Google Scholar 

  15. Kimmelstiel F, Lange M Fatal systemic strongyloidiasis following corticosteroid therapy. New York State Journal of Medicine 1984, 84: 399–401.

    PubMed  Google Scholar 

  16. McNeely DJ, Inouye T, Tam PYW, Ripley SD Acute respiratory failure due to strongyloidiasis in polymyositis. Journal of Rheumatology 1980, 7: 745–750.

    PubMed  Google Scholar 

  17. Chu E, Whitlock WL, Dietrich RA Pulmonary hyperinfection syndrome withStrongyloides stercoralis. Chest 1990, 97: 1475–1477.

    PubMed  Google Scholar 

  18. Sarubbi FA Hyperinfection withStrongyloides during treatment of pemphigus vulgaris. Archives of Dermatology 1987, 123: 864–865.

    PubMed  Google Scholar 

  19. Kebede D Strongyloidiasis and glucocorticoids: case report. Virginia Medical 1986, 113: 104–105.

    PubMed  Google Scholar 

  20. Yee A, Boylen CT, Noguchi T, Klatt EC, Sharma OP FatalStrongyloides stercoralis infection in a patient receiving corticosteroids. Western Journal of Medicine 1987, 146: 363–364.

    PubMed  Google Scholar 

  21. De Vault Jr GA, King JW, Rohr MS, Laudreneau MD, Brown III ST, McDonald JC Opportunistic infections withStrongyloides stercoralis in renal transplantation. Reviews of Infectious Diseases 1990, 12: 653–671.

    PubMed  Google Scholar 

  22. Morgan JS, Schaffner W, Stone WJ Opportunistic strongyloidiasis in renal transplant recipients. Transplantation 1986, 42: 518–524.

    PubMed  Google Scholar 

  23. Schad GA Cyclosporin may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. Journal of Infectious Diseases 1986, 153: 178.

    PubMed  Google Scholar 

  24. Genta RM, Lillibridge JP Prominence of IgG4 antibodies in the human responses toStrongyloides stercoralis infection. Journal of Infectious Diseases 1989, 160: 692–699.

    PubMed  Google Scholar 

  25. Petithory JC, Derouin F AIDS and strongyloidiasis in Africa. Lancet 1987, i: 921.

    Google Scholar 

  26. Gompels MM, Todd J, Peters BS, Main J, Pinching AJ Disseminated strongyloidiasis in AIDS: uncommon but important. AIDS 1991, 5: 329–332.

    PubMed  Google Scholar 

  27. Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. American Journal of Medicine 1992, 92: 202–208.

    PubMed  Google Scholar 

  28. Grove DI, Dawkins HJS Effects of prednisolone on murine strongyloidiasis. Parasitology 1981, 83: 401–409.

    PubMed  Google Scholar 

  29. Genta RM, Ottesen EA, Neva FA, Walzer PD, Tanowitz HB, Wittner M Cellular responses in human strongyloidiasis. American Journal of Tropical Medicine and Hygiene 1983, 32: 990–994.

    PubMed  Google Scholar 

  30. Genta RM, Harper JS, Gam A, London WI, Neva FA Experimental disseminated strongyloidiasis inErythrocebus patas. II: Immunology. American Journal of Tropical Medicine and Hygiene 1984, 33: 444–450.

    PubMed  Google Scholar 

  31. Genta RM, Douce RW, Walzer PD Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. Journal of Clinical Microbiology 1986, 23: 1099–1103.

    PubMed  Google Scholar 

  32. Genta RM, Frei DF, Linke MJ Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis. Journal of Clinical Microbiology 1987, 25: 1505–1510.

    PubMed  Google Scholar 

  33. Genta RM, Ottesen EA, Poindexter R, Gam AA, Neva FA, Tanowitz HB, Wittner M Specific allergic sensitization toStrongyloides antigens in human strongyloidiasis. Laboratory Investigation 1983, 48: 633–638.

    PubMed  Google Scholar 

  34. Schindzielorz A, Edberg SC, Bia FJ Strongyloides stercoralis hyperinfection and central nervous system involvement in a patient with relapsing polychondritis. Southern Medical Journal 1991, 84: 1055–1057.

    PubMed  Google Scholar 

  35. Boken DJ, Leoni PA, Preheim LC Treatment ofStrongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clinical Infectious Diseases 1993, 16: 123–126.

    PubMed  Google Scholar 

  36. Grove DI Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Transactions of the Royal Society of Tropical Medicine and Hygiene 1982, 76: 114–118.

    PubMed  Google Scholar 

  37. Rossignol JF, Maisonneuve H Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1983, 77: 707–711.

    PubMed  Google Scholar 

  38. Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, Neu D, Aziz M Ivermectin for human strongyloidiasis and other intestinal helminths. American Journal of Tropical Medicine and Hygiene 1989, 40: 304–309.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Danish-Bangladesh Leprosy Mission, District Nilphamari, Bangladesh

    L. H. Hagelskjær

  2. Vestergade 79, 8000, Århus C, Denmark

    L. H. Hagelskjær

Authors
  1. L. H. Hagelskjær
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hagelskjær, L.H. A fatal case of systemic strongyloidiasis and review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1069–1074 (1994). https://doi.org/10.1007/BF02111831

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111831

Keywords

Search

Navigation